Antiviral activity of the green marine alga Ulva fasciata on the replication of human metapneumovirus

Revista do Instituto de Medicina Tropical de Sao Paulo

Volumn 52, Issue 1, 2010, Pages 3-10

  Mendes, Gabriella Da Silva ^a   Soares, Angélica Ribeiro ^a   Martins, Fernanda Otaviano ^a   De Albuquerque, Maria Carolina Maciel ^a   Costa, Sonia Soares ^a   Yoneshigue Valentin, Yocie ^a   Gestinari, Lísia Mônica De Souza ^a   Santos, Norma ^a   Romanos, Maria Teresa Villela ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Antiviral; Human metapneumovirus; Marine alga; Respiratory infection

Indexed keywords

ANTIVIRUS AGENT; CELL RECEPTOR; PLANT EXTRACT; ULVA FASCIATA EXTRACT; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; BIOLOGICAL ACTIVITY; CHEMICAL PROCEDURES; CYTOTOXICITY; DRUG MECHANISM; ENVIRONMENTAL FACTOR; EXTRACELLULAR SPACE; EXTRACTION AND EXTRACTS; GREEN ALGA; HUMAN; HUMAN METAPNEUMOVIRUS; INTRACELLULAR SPACE; MOLECULAR INTERACTION; NONHUMAN; PROPHYLAXIS; RESPIRATORY TRACT INFECTION; ULVA FASCIATA; VIRUS ENTRY; VIRUS INFECTION; VIRUS PARTICLE; VIRUS REPLICATION;

ANTIVIRAL AGENTS; HUMANS; METAPNEUMOVIRUS; MICROBIAL SENSITIVITY TESTS; ULVA; VIRUS REPLICATION;

EID: 77949722767     PISSN: 00364665     EISSN: 16789946     Source Type: Journal    
DOI: 10.1590/S0036-46652010000100002     Document Type: Article

References (54)

1. Adhikari U, Mateu CG, Chattopadhyay K, Pujol CA, Damonte EB, Ray B. Structure and antiviral activity of sulfated fucans from Stoechospermum marginatu. Phytochemistry. 2006;67:2474-82.
2. Alamsjah MA, Hirao S, Ishibashi F, Fujita Y. Isolation and structure determination of algicidal compounds from Ulva fasciata. Biosci Biotechnol Biochem. 2005;69:2186-92.
3. Albuquerque MC, Pena GP, Varella RB, Gallucci G, Erdman D, Santos N. Novel respiratory virus infections in children, Brazil. Emerg Infect Dis. 2009;15:806-8.
4. Awad NE. Biologically active steroid from the green alga Ulva lactuca. Phytother Res. 2000;14:641-3.
5. Bellei N, Carraro E, Perosa A, Watanabe A, Arruda E, Granato C. Acute respiratory infection and influenza-like illness viral etiologies in Brazilian adults. J Med Virol. 2008;80:1824-7.
6. Bravin IC, Yoneshigue-Valentin Y. Influência de fatores ambientais sobre o crescimento in vitro de Hypnea musciformis (Wulfen) Lamouroux (Rhodophyta). Rev Bras Bot. 2002;25:469-74.
7. Canducci F, Debiaggi M, Sampaolo M, Marinozzi MC, Berre S, Terulla C, et al. Two-year prospective study of single infections and co-infections by respiratory syncytial virus and viruses identified recently in infants with acute respiratory disease. J Med Virol. 2008;80:716-23.
8. Carneiro BM, Yokosawa J, Arbiza J, Costa LF, Mirazo S, Nepomuceno LL, et al. Detection of all four human metapneumovirus subtypes in nasopharyngeal specimens from children with respiratory disease in Uberlândia, Brazil. J Med Virol. 2009;81:1814-18.
9. Chen M, Griffith BP, Lucia HL, Hsiung GD. Efficacy of S26308 against guinea pig cytomegalovirus infection. Antimicrob Agents Chemother. 1988;32: 678-83.
10. Damonte EB, Neyts J, Pujol CA, Snoeck R, Andrei G, Ikeda S, et al. Antiviral activity of a sulphated polysaccharide from the red seaweed Nothogenia fastigiata. Biochem Pharmacol. 1994;47:2187-92.
11. Damonte EB, Matulewicz MC, Cerezo AS, Coto CE. Herpes simplex virus - inhibitory sulfated xylogalactans from the red seaweed Nothogenia fastigiata. Chemotherapy. 1996;42:57-64.
12. Deffrasnes C, Hamelin ME, Boivin G. Human metapneumovirus. Semin Respir Crit Care Med. 2007;28:213-21.
13. Dieg EF, Ehresmann DW, Hatch MT, Riedlinger DJ. Inhibition of herpesvirus replication by marine algae extracts. Antimicrob Agents Chemother. 1974;6:524-5.
14. Duarte ME, Noseda DG, Noseda MD, Tulio S, Pujol CA, Damonte EB. Inhibitory effect of sulfated galactans from the marine alga Bostrychia montagnei on herpes simplex virus replication in vitro. Phytomedicine. 2001;8:53-8.
15. Flodin C, Whitfield FB. 4-Hydroxybenzoic acid: a likely precursor of 2,4,6-tribromophenol in Ulva lactuca. Phytochemistry. 1999;51:249-55.
16. Gonzalez ME, Alarcón B, Carrasco L. Polysaccharides as antiviral agents: antiviral activity of Carrageenan. Antimicrob Agents Chemother. 1987;3:1388-93.
17. Haslin C, Lahaye M, Pellegrini M, Chermann JC. In vitro anti-HIV activity of sulfated cell-wall polysaccharides from gametic, carposporic and tetrasporic stages of the Mediterranean red alga Asparagopsis armata. Planta Med. 2001;67:301-5.
18. Hasui M, Matsuda M, Okutani K, Shigeta S. In vitro antiviral activities of sulfated polysaccharides from a marine microalga (Cochlodinium polykrikoides) against human immunodeficiency virus and other enveloped viruses. Int J Biol Macromol. 1995;17:293-7.
19. Ivanova V, Rouseva R, Kolarova M, Serkedjieva J, Rachev R, Manolova N. Isolation of a polysaccharide with antiviral effect from Ulva lactuca. Prep Biochem. 1994;24:83-97.
20. Kahn JS. Newly discovered respiratory viruses: significance and implications. Curr Opin Pharmacol. 2007;7:478-83.
21. Lahaye M, Ray B. Cell-wall polysaccharides from the marine green alga Ulva "rigida" (Ulvales, Chlorophyta) - NMR analysis of ulvan oligosaccharides. Carbohydr Res. 1996;283:161-73.
22. Leiro JM, Castro R, Arranz JA, Lamas J. Immunomodulating activities of acidic sulphated polysaccharides obtained from the seaweed Ulva rigida. C Agardh Int Immunopharmacol. 2007;7:879-88.
23. Mackay IM, Jacob KC, Woolhouse D, Walker K, Syrmis MW, Whiley DM. Molecular assays for detection of human metapneumovirus. J Clin Microbiol. 2003;41:100-5.
24. Mandal P, Mateu CG, Chattopadhyay K, Pujol CA, Damonte EB, Ray B. Structural features and antiviral activity of sulphated fucans from the brown seaweed Cystoseira indica. Antivir Chem Chemother. 2007;18:153-62.
25. Manoha C, Espinosa S, Aho SL, Huet F, Pothier P. Epidemiological and clinical features of HMPV, RSV and RVs infections in young children. J Clin Virol. 2007;38:221-6.
26. Mayer AMS, Hamann MT. Marine pharmacology in 2000: marine compounds with antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiplatelet, antituberculosis, and antiviral activities; affecting the cardiovascular, immune, and nervous systems and others miscellaneous mechanisms of action. Mar Biotechnol.(NY). 2004;6:37-52.
27. Mayer AMS, Rodríguez AD, Berlinck RGS, Hamann MT. Marine pharmacology in 2003-4: marine compounds with antihelmintic, antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiplatelet, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune, and nervous systems and others miscellaneous mechanisms of action. Comp Biochem Physiol C Toxicol Pharmacol. 2007;145:553-81.
28. Monto A. Epidemiology of viral respiratory infections. Am J Med. 2002;112:4S-12S.
29. Neyndorff HC, Bartel DL, Tufaro F, Levy JG. Development of a model to demonstrate photosensitized-mediated viral inactivation in blood. Transfusion. 1990;30:485-90.
30. Nicholson KG, Mcnally T, Silverman M, Simons P, Stockton JD, Zambon MC. Rates of hospitalization for influenza, respiratory syncytial virus and human metapneumovirus among infants and young children. Vaccine. 2006;24:102-8.
31. Oliveira DB, Durigon EL, Carvalho AC, Leal AL, Souza TS, Thomazelli LM, et al. Epidemiology and genetic variability of human metapneumovirus during a 4-year-long study in Southeastern Brazil. J Med Virol. 2009;81:915-21.
32. Pereira RC, Soares AR, Teixeira VL, Villaca R, Da Gama BAP. Variation in chemical defenses against herbivore in southwestern Atlantic Stypopodium zonale (Phaeophyta). Botanica Marina. 2004;47:202-8.
33. Pollesello P, Toffanin R, Eriksson O, Kilpeläinen I, Hynninen PH, Paoletti S, et al. Analysis of lipids in crude extracts by 13C nuclear magnetic resonance. Anal Biochem. 1993;214:238-44.
34. Pujol CA, Coto CE, Damonte EB. Determination of the antiviral activity of a naturally occurring sulfated xylomannan under various experimental conditions. Rev Argent Microbiol. 1995;27:91-8.
35. Riccetto AG, Silva LH, Spilki FR, Morcillo AM, Arns CW, Baracat EC. Genotype and clinical data of respiratory syncytial virus and metapneumovirus in Brazilian infants: a new perspective. Braz J Infect Dis. 2009;13: 35-9.
36. Rodde RSH, Varum KM, Larsen BA, Myklestad SM. Seasonal and geographical variation in the chemical composition of the red alga Palmaria palmata (L.) Kuntze. Botanica Marina. 2004;47:125-33.
37. Romanos MTV, Andrada-Serpa MJ, Santos MGM, Ribeiro ACF, Yoneshigue-Valentin Y, Costa SS, et al. Inhibitory effect of extracts of Brazilian marine algae on human T-cell lymphotropic virus type 1 (HTLV-1)-induced syncytium formation in vitro. Cancer Invest. 2002;20:46-54.
38. Sanina NM, Goncharova SN, Kostetsky EY. Seasonal changes of fatty acid composition and thermotropic behavior of polar lipids from marine macrophytes. Phytochemistry. 2008;69:1517-27.
39. Santos MGM, Lagrota MHC, Miranda MMFS, Yoneshigue-Valentin Y, Wigg MD. A screening for the antiviral effect of extracts from Brazilian marine algae against acyclovir resistant herpes simplex virus type 1. Botanica Marina. 1999;42:227-30.
40. Schaeffer DJ, Krylov VS. Anti-HIV activity of extracts and compounds from algae and cyanobacteria. Ecotoxicol Environ Saf. 2000;45:208-27.
41. Schildgen O, Glatzel T, Geikowski T, Scheibner B, Matz B, Bindl L, et al. Human metapneumovirus RNA in encephalitis patient. Emerg Infect Dis. 2005;11:467-70.
42. Serkedjieva J. Antiviral activity of the red marine alga Ceramium rubrum. Phytother. Res. 2004;18:480-83.
43. Sloots TP, Whiley DM, Lambert SB, Nissen MD. Emerging respiratory agents: new viruses for old diseases. J Clin Virol. 2008;42:233-43.
44. Van Alstyne KL, Pelletreau KN, Rosario K. The effects of salinity on Dimethylsulfoniopropionate production in the green alga Ulva fenestrata Postels et Ruprecht (Chlorophyta). Botanica Marina. 2003;46:350-6.
45. Van Alstyne KL, Koellermeier L, Nelson TA. Spatial variation in dimethylsulfoniopropionate (DMSP) production in Ulva lactuca (Chlorophyta) from the Northeast Pacific. Mar Biol. 2007;150:1127-35.
46. Van Den Hoogen BG, De Jong JC, Groen J, Kuiken T, de Groot R, Fouchier RA, et al. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med. 2001;7:719-24.
47. van Den Hoogen BG, Van Doornum GJ, Fockens JC, Cornelisse JJ, Beyer WE, de Groot R, et al. Prevalence and clinical symptoms of human metapneumovirus infection in hospitalized patients. J Infect Dis. 2003;188:1571-7.
48. Wang SC, Bligh SW, Shi SS, Wang ZT, Hu ZB, Crowder J, et al. Structural features and anti-HIV-1 activity of novel polysaccharides from red algae Grateloupia longifolia and Grateloupia filicina. Int J Biol Macromol. 2007;41:369-75.
49. Weigl JAI, Puppe W, Meyer CU, Berner R, Foster J, Schmitt HJ, et al. Ten years' experience with year-round active surveillance of up to 19 respiratory pathogens in children. Eur J Pediatr. 2007;166:957-66.
50. Williams JV, Harris PA, Tollesfson SJ, Halbarnt-Rush LL, Pingsterhaus JM, Edwards, KM, et al. Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N Engl J Med. 2004;350:443-50.
51. Witvrouw M, De Clercq E. Sulfated polysaccharides extracted from sea algae as potential antiviral drugs. Gen Pharmacol. 1997;29:497-511.
52. Wright JT, De Nys R, Steinberg PD. Geographic variation in halogenated furanones from the red alga Delisea pulchra and associated herbivores and epiphytes. Mar Ecol Prog Ser. 2000;207:227-41.
53. Wyde PR, Chetty SN, Jewell AM, Boivin G, Piedra PA. Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by ribavirin and immune serum globulin in vitro. Antiviral Res. 2003;60:51-9.
54. Wyde PR, Moylett EH, Chetty SN, Jewell A, Bowlin TL, Piedra PA. Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by NMSO3 in tissue culture assays. Antiviral Res. 2004;63:51-9.